Japan’s top science council has adopted policy recommendations that would permit limited cloning of human embryos for scientific research. An Associated Press story reprinted in the L.A. Times gives the details.
Japan banned human cloning in 2001, but researchers have been allowed to study embryonic stem cells not produced by cloning. The new recommendations would let researchers produce and use cloned human embryos–but only for basic research. The cloned cells won’t be allowed for use in treating human patients, so-called therapeutic cloning. Still, stem cell biologists believe such basic research using cloned stem cells could help them unravel diseases such as cancer, Alzheimer’s, and Parkinson’s.
Britain and South Korea allow therapeutic cloning, while the U.S. prohibits the use of federal funds for any kind of human cloning and is considering laws that would ban it.
Embracing CX in the metaverse
More than just meeting customers where they are, the metaverse offers opportunities to transform customer experience.
Identity protection is key to metaverse innovation
As immersive experiences in the metaverse become more sophisticated, so does the threat landscape.
The modern enterprise imaging and data value chain
For both patients and providers, intelligent, interoperable, and open workflow solutions will make all the difference.
Scientists have created synthetic mouse embryos with developed brains
The stem-cell-derived embryos could shed new light on the earliest stages of human pregnancy.
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.